COVID-19 pulmonary phenotypes and longitudinal patterns in the first wave of the pandemic

Davide Chimera1, Sara Maio2, Chiara Romei3

  • 1Pulmonary Unit, Cardiothoracic and Vascular Department, Pisa University Hospital, Pisa, Italy.

Respiratory Medicine
|January 18, 2025
PubMed

Insights

Long COVID can cause persistent lung issues. This study identified distinct pulmonary phenotypes and recovery patterns in first-wave COVID-19 patients, with severe cases and comorbidities indicating longer-term lung problems.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Epidemiology

Background:

  • Long-term pulmonary evolution in first-wave COVID-19 patients is understudied.
  • Understanding post-COVID-19 lung phenotypes is crucial for patient management.

Purpose of the Study:

  • To identify COVID-19 pulmonary phenotypes.
  • To analyze longitudinal recovery patterns over 12 months post-hospitalization.
  • To determine risk factors associated with specific recovery trajectories.

Main Methods:

  • Latent transition analysis (LTA) applied to spirometry, lung volumes, DLCO, and chest CT data.
  • Follow-up assessments at 3, 12, and 24 months post-discharge.
  • Multinomial logistic regression used to identify risk factors.

Main Results:

  • Three cross-sectional phenotypes (no PS/normal PFTs, PS/normal PFTs, PS/impaired PFTs) identified at 3 and 12 months.
  • Four longitudinal patterns from 3 to 12 months: full recovery, resolution of PS, persistent PS with normal PFTs, persistent PS with impaired PFTs.
  • Persistent pulmonary issues (PS and/or impaired PFTs) observed in a significant proportion up to 24 months, linked to hospitalization duration, comorbidities, and disease severity.

Conclusions:

  • Distinct pulmonary phenotypes and longitudinal recovery patterns exist in first-wave COVID-19 survivors.
  • Comorbidities and severe acute COVID-19 are associated with poorer long-term pulmonary outcomes.
  • Long-term monitoring is recommended for high-risk COVID-19 patients.
Abstract

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
228
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K